Leading intellectual property firm Mathys & Squire LLP has announced the promotion of attorneys David Hobson, Juliet Redhouse and Andrew White to the partnership. The firm now has 30 partners and 10 offices across the UK and Europe.
Working in the life sciences team, David Hobson has a background in biochemistry and represents UK and overseas clients in a range of industries. He demonstrates particular skill at drafting and prosecuting challenging life sciences subject matter through to the grant of commercially-relevant patents. David’s principal sectors of expertise include biotechnology, pharmaceuticals, and food and beverages, encompassing enzyme biotechnology, therapeutic antibodies, and cell-based therapies. He is also experienced in providing therapeutic freedom to operate and validity advice, and handling opposition proceedings before the EPO. Some key hearings include: “Recombinant EPO” (Sterrenbeld Biotechnologie; Polymun Scientific Immunbiologische), “Modified Clostridial Neurotoxins” (Ipsen Bioinnovation; Merz Pharma), and “Antibody-Containing Stabilized Preparations” (Chugai Seiyaku Kabushiki Kaisha; Mathys & Squire).
Juliet Redhouse also works in the firm’s life sciences team, specialising in molecular biology, pharmaceuticals, and biotechnology. With particular expertise in the areas of antibody technology, vaccine technology, protein and peptide based medicines, formulations, personalised medicine and diagnostic assays, Juliet is experienced in examination and opposition proceedings at the EPO, as well as drafting, prosecution, and management of global patent portfolios. She also advises clients on infringement, validity and freedom-to-operate.
Andrew White is part of the firm’s IT & engineering team, with extensive experience managing international portfolios in the med-tech, software, telecoms, and automotive sectors, with a specific focus on electric vehicle and AI-based technologies. Andrew is very active in the startup community, working with a number of accelerators and incubators, providing regular workshops and one-to-one clinics covering all aspects of IP ranging from ownership and licensing to patent filing strategies. He frequently presents at tech and startup focused events, and is regularly published in both IP and industry publications.
Commenting on the new appointments, partner Alan MacDougall said: “We are delighted to welcome these next generation partners to further enhance our high-level skills across two of the firm’s core sectors. Their promotions are testament to not only their success and expertise in their individual fields, but also to the passion and dedication they bring to their clients.
“We are confident that the firm will benefit from the appointment of such talented and focused individuals, who clearly represent the firm’s core values of both technical and commercial excellence and will continue to drive this focus as they progress their careers as partners. We wish David, Juliet and Andrew the best of luck as they join the Mathys & Squire partnership.”
Mathys & Squire LLP is one of the leading IP firms in Europe with tier 1 rankings in all the main legal and IP directories. With offices in London, Cambridge, Manchester, York, Brighton, Oxford, Midlands, Paris, Luxembourg and Munich as well as a team in China, the firm offers a full range of services dedicated to identifying, protecting and maximising the value of clients’ innovations, technologies, brands and designs. The firm’s patent, trade mark and design attorneys are qualified at both a UK and European level, with legal expertise across a full spectrum of technical proficiencies and sectors.
